优化侵袭性角膜炎的治疗 - - 结合疗法的案例
Rachel M Wake1,2, Phoebe E Allebone-Salt1,2, Larissa L H John3
1Institute for Infection and Immunity, St George's University of London, London, UK.
Open forum infectious diseases
|June 18, 2024
概括
抗真菌组合疗法在对抗侵入性候群病和药物耐药性方面显示出有前途. 临床试验至关重要,以验证这些发现,并改善患者对Candida感染的治疗结果.
科学领域:
- 医学真菌学 医学真菌学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 侵袭性角膜炎是一种日益严重的全球健康挑战,死亡率高,治疗方法有限.
- 抗真菌耐药性正在迅速增加,多药耐药物种构成严重威胁.
- 抗真菌单一治疗可能有助于药物耐药性的发展.
研究的目的:
- 检查抗真菌单一治疗在驱动电阻中的作用.
- 探索组合治疗在预防抗真菌耐药性和改善治疗结果方面的潜力.
- 评估抗真菌组合对Candida物种的协同作用.
主要方法:
- 对抗真菌组合疗法的现有实验室证据的审查.
- 分析组合疗法可以减轻耐药性的机制.
- 考虑结合抗性终点的临床试验设计.
主要成果:
- 实验室证据表明,抗真菌组合可以表现出对Candida物种的协同作用.
- 组合疗法可以防止应激适应和药物耐药性的出现.
- 潜在的好处包括改善药物透率,更快的真菌清除,以及降低毒性.
结论:
- 抗真菌联合治疗是一种有前途的策略,用于对抗侵袭性候群病和新出现的耐药性.
- 进一步的临床试验是必要的,以验证这些组合的疗效和安全性.
- 在试验中纳入耐药性终点对于评估治疗成功至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156


